Actively Recruiting
Global Long-Term Observational Study of Friedreich Ataxia to Understand Disease Progression and Support Treatment Development
Led by Friedreich's Ataxia Research Alliance · Updated on 2026-09-01
3000
Participants Needed
34
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a global, multicenter, prospective, longitudinal observational study to understand the natural progression of Friedreich ataxia, a rare inherited neurological and cardiac disorder caused by mutations in the FXN gene. The study brings together data from previous large natural history studies to enhance knowledge of the disease and support the development of safe and effective treatments. Participants diagnosed with Friedreich ataxia will be assessed annually for up to 25 years. Data collected includes clinical outcome assessments such as neurological exams, timed walking tests, upper limb function measures, and patient-reported quality of life. Additional optional measures may include speech, vision, fatigue, balance, and cognition. This study does not involve investigational treatments but monitors the disease progression and effects of any therapies participants may be receiving. Participants will attend yearly visits where medical records, history, laboratory tests, and various clinical and functional assessments are collected. Researchers will evaluate changes in several neurological and functional scores over time, such as the modified Friedreich Ataxia Rating Scale, Scale for the Assessment and Rating of Ataxia, and activities of daily living. The study aims to identify clinical milestones and inform future clinical trial design while continuing long-term monitoring for up to 25 years.
CONDITIONS
Brief Title
Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
Research Team
M
Mackenzi Coker
J
Jennifer Farmer
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here